Pharma Reviews: BSE Healthcare index decline by 13% during 2016

The BSE Healthcare index of 69 pharmaceutical companies declined ... The Pharmabiz study of 30 top Indian pharma companies in the first half of the ...
Read more: BSE Healthcare index decline by 13% during 2016

Pharma Reviews: 5 trends to watch out for in the pharma sector in 2017

Profit margins of Indian companies selling generics in the US will remain under pressure in 2017 with channel consolidation and USFDA fast tracking ...
Read more: 5 trends to watch out for in the pharma sector in 2017

Pharma Reviews: Union Cabinet approves sale of India's first pharmaceutical firm

New Delhi: In the second strategic sale approval in over 12 years, the Union Cabinet on Wednesday cleared the sale of India's first pharma company ...
Read more: Union Cabinet approves sale of India's first pharmaceutical firm

Pharma Reviews: Indian lifesciences industry perceives start-ups & digital ecosystem to spur innovation

The huge potential of the Indian pharmaceuticals market cannot be ignored by the foreign companies in view of the fact that it will be one of the top 10 ...
Read more: Indian lifesciences industry perceives start-ups & digital ecosystem to spur innovation

Pharma Reviews: 'Government must steer clear of doctors' conference funded by pharma firms'

'Government must steer clear of doctors' conference funded by pharma firms' JAIPUR: American Association of Physicians of Indian Origin (AAPI) is ...
Read more: 'Government must steer clear of doctors' conference funded by pharma firms'

Pharma Reviews: Cabinet OKs sale of India's first pharma company

NEW DELHI: In the second strategic sale approval in over 12 years, the Union Cabinet cleared on Wednesday the sale of India's first pharma company ...
Read more: Cabinet OKs sale of India's first pharma company

Pharma Reviews: Cabinet Approves Sale Of India's First Pharma Firm

In the second strategic sale approval in over 12 years, the Cabinet on Wednesday cleared the sale of India's first pharma company Bengal Chemicals ...
Read more: Cabinet Approves Sale Of India's First Pharma Firm

Pharma Reviews: 2016: A mixed bag for Indian pharma

This is the largest overseas acquisition by an Indian pharma company. Intas is backed by PE giant Temasek and Chrys Capital. This clearly showed ...
Read more: 2016: A mixed bag for Indian pharma

Pharma Reviews: Govt approves sale of India's first pharma company and 3 others

The three other public sector pharma firms include Hindustan Antibiotics Limited (HAL), Indian Drugs & Pharmaceuticals Limited (IDPL) and Rajasthan ...
Read more: Govt approves sale of India's first pharma company and 3 others

Pharma Reviews: Cabinet Approves Sale Of India's First Pharma Company

The Union Cabinet chaired by the Prime Minister Narendra Modi on Wednesday approved strategic sale of India's first pharmaceutical company, ...
Read more: Cabinet Approves Sale Of India's First Pharma Company

Pharma Reviews: 'Government must steer clear of doctors' conference funded by pharma firms'

Among sponsors are also the two largest pharmaceutical company associations in India, Organization of Pharmaceutical Producers of India (OPPI) ...
Read more: 'Government must steer clear of doctors' conference funded by pharma firms'

Pharma Reviews: Specialty drugs to remain focus of pharma deals in 2017

Growth rate in the generic drugs business is slowing due to pricing pressure in the US, the biggest market for Indian pharma majors. Photo: Pradeep ...
Read more: Specialty drugs to remain focus of pharma deals in 2017

Pharma Reviews: Cadila Healthcare arm acquires six brands from MSD Pharma for India market

Mumbai: Cadila Healthcare on Wednesday said its subsidiary Zydus Healthcare Ltd has bought six brands from MSD Pharmaceuticals India Pvt. Ltd, ...
Read more: Cadila Healthcare arm acquires six brands from MSD Pharma for India market

Pharma Reviews: Cabinet okays sale of India's first pharma firm

NEW DELHI: In the second strategic sale approval in over 12 years, the Cabinet today cleared the sale of India's first pharma company Bengal ...
Read more: Cabinet okays sale of India's first pharma firm

Pharma Reviews: Dr. Piyush Gupta, Associate Director, GNH India

GNH India is India's leading global pharmaceutical wholesale distributor. A multifaceted pharmaceutical enterprise with presence in International ...
Read more: Dr. Piyush Gupta, Associate Director, GNH India

Pharma Reviews: Indian pharma companies improved credibility in 2016: Nomura

Indian pharmaceutical companies have signed off 2016 on a positive note and can look forward to improving their performance in the coming year ...
Read more: Indian pharma companies improved credibility in 2016: Nomura

Pharma Reviews: INSIGHT-Serial testers and cursory checks: India's flawed generic drug tri...

Still, the serial testing of some volunteers is raising new questions about the level of oversight of India's generic drug trials industry, after some CROs ...
Read more: INSIGHT-Serial testers and cursory checks: India's flawed generic drug tri...

Pharma Reviews: Backdoor patents could hurt patients

Earlier this month the Indian Pharmaceutical Alliance was up in arms over a proposed rule change being considered by the Centre to provide a longer ...
Read more: Backdoor patents could hurt patients

Pharma Reviews: Did a US Firm Use a Doctor-Industry Nexus in India To Push Through an Untested Drug?

According to the BMJ: “Health camps have become an industry-wide marketing gimmick in India. Violating national law, pharmaceutical sales agents ...
Read more: Did a US Firm Use a Doctor-Industry Nexus in India To Push Through an Untested Drug?

Pharma Reviews: Pharma's stumble after six-year run may offer value buys

"Because of this tightening of (US) FDA regulations, there are observations or import bans on plants of Indian pharma companies. This is responsible ...
Read more: Pharma's stumble after six-year run may offer value buys

Pharma Reviews: As India braces for Trump in 2017, some signals to watch out for

The software industry body has already revised growth for the sector ... Trump is no friend of this programme and if he scraps it, Indian pharma, a few ...
Read more: As India braces for Trump in 2017, some signals to watch out for

Pharma Reviews: Pharma's stumble after six-year run may offer value buys

“Because of this tightening of (US) FDA regulations, there are observations or import bans on plants of Indian pharma companies. This is responsible ...
Read more: Pharma's stumble after six-year run may offer value buys

Pharma Jobs: Hiring Fresher candidates for International Voice to solve Health-care issues @ Ramapuram

Company: 2COMS Consulting Private Limited
Experience: 0 to 1
Salary: 1.20 to 1.50
location: Chennai
Ref: 19851253
Summary: Leading MNC hiring Fresher candidates to resolve International Customers queries regarding Healthcare. Solve the queries through Inbound Voice. Candidates will be hired only if they stay within 30....
Read more: Hiring Fresher candidates for International Voice to solve Health-care issues @ Ramapuram

Pharma Reviews: Flashback 2016: Healthcare firms ride the IPO wave; M&As flourish

“Rapid changes in the Indian healthcare sector and tailwinds to propel the ... Besides, India's biggest drugmaker Sun Pharmaceuticals acquired 14 ...
Read more: Flashback 2016: Healthcare firms ride the IPO wave; M&As flourish

Pharma Reviews: Glucorade, A Revolution In 2000 Crore Confectionary Market.

Glucorade is a product of Bentley and Remington Pvt Ltd, who are also the leading manufacturers in Indian Pharma industry with well known brands ...
Read more: Glucorade, A Revolution In 2000 Crore Confectionary Market.

Pharma Reviews: 'Indian pharma companies don't make drugs because of insufficient revenue'

Most drugs for treatment are not manufactured in India. Pharmaceutical companies may not be interested in developing drugs because these are ...
Read more: 'Indian pharma companies don't make drugs because of insufficient revenue'

Pharma Reviews: Clariant eyes 20% growth on rising Indian generic export to US, other regulated markets

Indian pharma industries opt for barrier packaging solutions when it comes to domestic market while active packaging solutions like dessicant ...
Read more: Clariant eyes 20% growth on rising Indian generic export to US, other regulated markets

US FDA News: FDA approves first drug for spinal muscular atrophy

The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord.
Read more: FDA approves first drug for spinal muscular atrophy

US FDA News: ZIKV Detect IgM Capture ELISA by InBios International, Inc: FDA Safety Communication - Wait for Confirmatory Test Results Before Making Patient Management Decisions

IgM tests remain useful in ruling out Zika exposure, but require confirmatory testing. Do not rely on presumptive positive Zika virus IgM test results as the sole basis of significant patient management decisions.
Read more: ZIKV Detect IgM Capture ELISA by InBios International, Inc: FDA Safety Communication - Wait for Confirmatory Test Results Before Making Patient Management Decisions

Pharma Reviews: Sun Pharmaceutical's arm buys 14.6 per cent stake in US-based scPharmaceuticals for around Rs ...

Indian pharma giant Sun Pharmaceutical on Friday said that its subsidiary ... The stock of Sun Pharma was trading 2.59 per cent higher at Rs 625 on ...
Read more: Sun Pharmaceutical's arm buys 14.6 per cent stake in US-based scPharmaceuticals for around Rs ...

Pharma Reviews: Pharma hiring trends for 2017 indicate robust manpower growth across quality control & manufacture

Indian pharma industry which showed robust hiring of qualified candidates in quality control and manufacturing departments in 2016 is expected to ...
Read more: Pharma hiring trends for 2017 indicate robust manpower growth across quality control & manufacture

Pharma Reviews: Myanmar govt proposes tender for massive purchase of generic medicines

He further said that Indian pharma companies have a strong presence in Myanmar and Indian drugs are preferred for its quality at a reasonable cost.
Read more: Myanmar govt proposes tender for massive purchase of generic medicines

Pharma Reviews: Medical Device Manufacturing High on Agenda of Govt. of Gujarat - A Dedicated Seminar on ...

The theme seminar on pharmaceutical & medical device manufacturing is an ... Gujarat and India's favorable environment for industrial manufacturing, ...
Read more: Medical Device Manufacturing High on Agenda of Govt. of Gujarat - A Dedicated Seminar on ...

Pharma Reviews: Indian pharma eyes pride of place, regulation Achilles heel

The $32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises, especially in ...
Read more: Indian pharma eyes pride of place, regulation Achilles heel

Pharma Reviews: Indian pharma eyes pride of place, may face regulatory hurdles

The USD 32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises, ...
Read more: Indian pharma eyes pride of place, may face regulatory hurdles

Pharma Reviews: Top 15 stocks in focus today: Sun Pharmaceutical, South Indian Bank, Godrej Properties

Sun Pharmaceutical Industries Ltd: Sun Pharmaceutical and includes its ... South Indian Bank: The bank said its board has approved issuing one ...
Read more: Top 15 stocks in focus today: Sun Pharmaceutical, South Indian Bank, Godrej Properties

Pharma Reviews: Sun pharma & taro's class action suit

Sun pharma & taro's class action suitSun pharma & taro's class action suit - Image Taro Pharmaceutical, the American unit of India's Sun ...
Read more: Sun pharma & taro's class action suit

US FDA News: FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft tissue deformities. A patient uses a dose controller to independently inflate the expander.
Read more: FDA permits marketing of new tissue expander for women undergoing breast reconstruction following mastectomy

Pharma Reviews: COMMENT: Is Sun Pharma suffering on account of unrelated diversification?

Ironically the acquisition comes at a time when Sun Pharma, along with other Indian pharmaceutical companies, is facing unprecedented regulatory ...
Read more: COMMENT: Is Sun Pharma suffering on account of unrelated diversification?

Pharma Reviews: 68th IPC concludes in Vizag giving good hope for future

The 68th Indian Pharmaceutical Congress (IPC) in Visakhapatnam concluded at University College of Pharmaceutical Sciences in Andhra University, ...
Read more: 68th IPC concludes in Vizag giving good hope for future

Pharma Reviews: “There is power struggle as well as ideological struggle in the government”

Also, the Indian Pharmaceutical Alliance has been losing some cases in the courts relating to DPCO, so they are getting desperate. Actually, there is ...
Read more: “There is power struggle as well as ideological struggle in the government”

Pharma Reviews: “In 50% of the Indian pharma sector, oligopolistic conditions prevail”

In an edifying chat with Kaushal Shroff, he explains the inner mechanics of the DPCO and speaks on why pharma companies are so keen to see a ...
Read more: “In 50% of the Indian pharma sector, oligopolistic conditions prevail”

Pharma Reviews: What class action suit against Taro means for Sun Pharma

MUMBAI: Taro Pharmaceutical, the American unit of India's Sun Pharmaceutical Industries, is being sued by its investors for what they allege making ...
Read more: What class action suit against Taro means for Sun Pharma

Pharma Reviews: Price collusion charges of US DoJ may impact Indian pharma cos adversely: ICRA

“Nonetheless, such increased generic pricing related scrutiny is a concern for Indian pharmaceutical companies; and given the heightened focus on ...
Read more: Price collusion charges of US DoJ may impact Indian pharma cos adversely: ICRA

US FDA News: FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions

The U.S. Food and Drug Administration today expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose (sugar) testing for diabetes treatment decisions in people 2 years of age and older with diabetes.
Read more: FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions

US FDA News: Standard Offset Cup Impactor with POM-C Handle by Greatbatch Medical: Class I Recall - Inadequate Sterilization

Non-sterile surgical devices can lead to infections, and other serious adverse health consequences, including death.
Read more: Standard Offset Cup Impactor with POM-C Handle by Greatbatch Medical: Class I Recall - Inadequate Sterilization

Pharma Reviews: How Indian Pharma Gets Away With Selling Substandard Drugs

It's used largely against foreign regulators who call Indian pharma companies out on quality. At the core of this strategy is the allegation that the foreign ...
Read more: How Indian Pharma Gets Away With Selling Substandard Drugs

Pharma Reviews: Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma

In a BSE filing, Sun Pharmaceutical Industries said: “One of the company's wholly-owned subsidiaries has voluntarily requested the USFDA to ...
Read more: Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma

Pharma Reviews: Indian pharma views streamlined logistics key to successful supply chain management

Indian pharma industry sees that logistics is the key for the successful supply chain management of drugs. The sector which handles huge stock ...
Read more: Indian pharma views streamlined logistics key to successful supply chain management

Pharma Reviews: 'Pharma industry's playbook on low-quality drugs'

The Indian pharma industry has a playbook when the quality crisis within the sector is exposed. It has four strategies, unfortunately none of them ...
Read more: 'Pharma industry's playbook on low-quality drugs'

Pharma Reviews: Substandard drugs: Recall system in the works

India has 36 drug regulators. There is one ... If a firm finds a drug as substandard, it would have to voluntarily recall the whole batch from the market.
Read more: Substandard drugs: Recall system in the works

Pharma Reviews: Pharmaceutical sector hiring set for double-digit growth

NEW DELHI: As some industries brace for slow hiring in the coming months, the Indian pharmaceutical sector's recruitment numbers are poised to ...
Read more: Pharmaceutical sector hiring set for double-digit growth

US FDA News: FDA grants accelerated approval to new treatment for advanced ovarian cancer

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.
Read more: FDA grants accelerated approval to new treatment for advanced ovarian cancer

Pharma Reviews: Recent charges of price collusion among generic drug manufacturers to have serious implications ...

Nonetheless, such increased generic pricing related scrutiny is a concern for Indian pharmaceutical companies; and given the heightened focus on ...
Read more: Recent charges of price collusion among generic drug manufacturers to have serious implications ...

Pharma Reviews: Metal, oil & gas sectors see sharpest rally in seven years in CY16

A depreciation in currency would help the Indian IT companies improve their margins significantly. Pharma stocks, however, could underperform given ...
Read more: Metal, oil & gas sectors see sharpest rally in seven years in CY16

Pharma Reviews: Make In Odisha - Biotechnologies and Pharmaceuticals: An Emerging New Business Development ...

Global pharma is a $1000 billion industry (2015 sales) and Indian pharma is a $25 billion industry (2015 sales). Indian BioAgri sector had total sales of ...
Read more: Make In Odisha - Biotechnologies and Pharmaceuticals: An Emerging New Business Development ...

Pharma Reviews: 'Government needs to supportpharma sector'

Against this background, the support from the government is not encouraging, according to chairman of Indian Pharmaceutical Congress Association ...
Read more: 'Government needs to supportpharma sector'

Pharma Reviews: Three-day IPC concludes

According to him, the India pharmaceuticals market is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020 as among the top ...
Read more: Three-day IPC concludes

Pharma Reviews: Indian pharma industry set for a leap: PDA

The Indian pharma industry is set for a great leap forward in the coming years and therefore all the stakeholders should brace up for the development, ...
Read more: Indian pharma industry set for a leap: PDA

Pharma Reviews: Naidu invites pharma players to set up units in Andhra Pradesh

Naidu invites pharma players to set up units in Andhra Pradesh ... Naidu was speaking on the second day of the 68th Indian Pharmaceutical Congress ...
Read more: Naidu invites pharma players to set up units in Andhra Pradesh

Pharma Reviews: India Markets Weekahead: Cautious days ahead

A broker trades on his computer terminal at a stock brokerage firm in ... The Indian pharma industry's ongoing troubles with global regulators and ...
Read more: India Markets Weekahead: Cautious days ahead

Pharma Reviews: Top pharma firms hike complex drug R&D spend to Rs 8500 crore in 2015-16, eye buyouts

According to ICRA, almost all the major Indian pharmaceutical companies have materially stepped up R&D expenses over last few years. The top ...
Read more: Top pharma firms hike complex drug R&D spend to Rs 8500 crore in 2015-16, eye buyouts

Pharma Reviews: Pharma congress gets under way

Iranian students, who completed B. Pharmacy in Andhra University last year, attending the Indian Pharmaceutical Congress as delegates going round ...
Read more: Pharma congress gets under way

Pharma Reviews: Cipla: Healthy growth

This was due to the Indian Health Ministry's move in March 2016, banning ... In September 2015, Cipla acquired two generic US pharma companies ...
Read more: Cipla: Healthy growth

Pharma Reviews: Naidu invites pharma players to set up units in Andhra Pradesh

Naidu was speaking on the second day of the 68th Indian Pharmaceutical Congress (IPC) at the Andhra University Grounds here. The event, being ...
Read more: Naidu invites pharma players to set up units in Andhra Pradesh

Pharma Reviews: Naidu invites pharma players to set up units in Andhra Pradesh

Naidu was speaking on the second day of the 68th Indian Pharmaceutical ... Naidu said several companies have already established their units and ...
Read more: Naidu invites pharma players to set up units in Andhra Pradesh

Pharma Reviews: 2500 papers to be presented at 3-day 68th Indian Pharmaceutical Congress

VISAKHAPATNAM : The three-day 68th Indian Pharmaceutical Congress (IPC) began at Andhra University on Friday where thousands of delegates ...
Read more: 2500 papers to be presented at 3-day 68th Indian Pharmaceutical Congress

US FDA News: Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised

FDA determined the risk of serious side effects on mood, behavior, or thinking is lower than previously suspected.
Read more: Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised

Pharma Reviews: Top pharma firms hike complex drug R&D spend to Rs 8500 crore in 2015-16, eye buyouts

HYDERABAD: Leading Indian drug makers have sharply increased their R&D budgets over the past five years, as they stare at tempered growth in the ...
Read more: Top pharma firms hike complex drug R&D spend to Rs 8500 crore in 2015-16, eye buyouts

Pharma Reviews: Andhra Pradesh best destination for pharma units: Minister

Andhra Pradesh is the best destination in the country to set up pharma industries as the State Government has devised policies conducive for such ...
Read more: Andhra Pradesh best destination for pharma units: Minister

Pharma Reviews: Andhra Pradesh best destination for pharma units: Minister

Rao was speaking was after inaugurating the 68th Indian Pharmaceutical Congress (IPC) at the Andhra University Grounds here. Andhra Pradesh is ...
Read more: Andhra Pradesh best destination for pharma units: Minister

Pharma Reviews: Enter characters of the above image

This week, Anuh Pharma got approval for pharmaceutical products, ... the manufacturing cost advantage that India presents, the Pharma industry is ...
Read more: Enter characters of the above image

Pharma Reviews: Pharmexcil, AIDCOC to organize symposium on 'IPR & Regulatory Perspective for Pharma ...

... Visakhapatnam, A.P. The event will coincide with the 68th Indian Pharmaceutical Congress (IPC) being held at Visakhapatnam from December 17 ...
Read more: Pharmexcil, AIDCOC to organize symposium on 'IPR & Regulatory Perspective for Pharma ...

Product Recall Alerts: Health Alerts: Baby food, nightlights, and more recalled

The recalled teething tablets and ear relief liquids contain levels of belladonna that vary from the label, according to the Food and Drug Administration ...
Read more: Health Alerts: Baby food, nightlights, and more recalled

Pharma Reviews: Maharashtra eyes numero uno position in medical tourism

India receives a lot of medical tourists particularly for this segment. ... Indian pharmaceutical industry has become way more advanced in the last ...
Read more: Maharashtra eyes numero uno position in medical tourism

Pharma Reviews: 2017 to be a good year for Pharma sector; hiring to go up by 20-25%: Teamlease

The positive sentiment in the sector will give a fillip to fresher hiring as well. ... In fact, India is most likely to emerge as among the top Pharma players ...
Read more: 2017 to be a good year for Pharma sector; hiring to go up by 20-25%: Teamlease

Pharma Reviews: 68th Indian Pharmaceutical Congress in Vizag from Dec 16

Visakhapatnam, Dec 14 (PTI) The 68th Indian Pharmaceutical Congress (IPC) will be held at the Andhra University here from December 16 to 18.
Read more: 68th Indian Pharmaceutical Congress in Vizag from Dec 16

Pharma Reviews: CPhI SEA exhibition: Contributing to Indonesia President Call on Indian Pharma to Set Up Shop in ...

In particular, President Widodo called on Indian firms to set up shop in Indonesia to invest in its fast growing, strategic pharmaceutical industry and ...
Read more: CPhI SEA exhibition: Contributing to Indonesia President Call on Indian Pharma to Set Up Shop in ...

Pharma Jobs: Chemist

Company: Confidential
Qualification: B.Sc
Experience: 0 to 5
Salary: 2.50 to 5.00
location: Ahmedabad
Ref: 18306202
Summary: We are a Leading Colour solution Company,established on 1923, Manufacturing colour Solutions for Fmcg, Agro chemicals,Cosmetics,Food Products,Textiles,Cement,Lubricating Oils & Grease,....
Read more: Chemist

Pharma Reviews: India Pharma 2017 to be held in Bengaluru from February 11 to13, 2017

The Department of Pharmaceuticals, in association with the Federation of Indian Chambers of Commerce & Industry (FICCI) will be holding the India ...
Read more: India Pharma 2017 to be held in Bengaluru from February 11 to13, 2017

US FDA News: FDA approves Eucrisa for eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
Read more: FDA approves Eucrisa for eczema

Pharma Reviews: Cipla's path-breaking succession formula

But what was indisputable was that Hamied had changed the face of the Indian pharmaceutical industry by providing access to low-cost drugs, and at ...
Read more: Cipla's path-breaking succession formula

US FDA News: FDA Statement from Dr. Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, on new safety information on anesthesia use in young children and pregnant women

The health of our nation’s children is a responsibility that the FDA takes very seriously. Parents and caregivers are often concerned when their young child requires a medical procedure for which anesthesia or sedation drugs are necessary. Understandably, there are many questions, including whether the drugs are safe for their child. Pregnant women who must undergo medical procedures that require anesthesia or sedation drugs have similar concerns.
Read more: FDA Statement from Dr. Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research, on new safety information on anesthesia use in young children and pregnant women

US FDA News: General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women

Published studies in pregnant animals and young animals have shown the use of general anesthetic and sedation drugs for more than 3 hours caused widespread loss of nerve cells in the brain.
Read more: General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women

US FDA News: FDA takes action on applications seeking to market modified risk tobacco products

The U.S. Food and Drug Administration today took action on the first applications reviewed through the modified risk tobacco product (MRTP) pathway for eight Swedish Match North America Inc. snus smokeless tobacco products sold under the General brand name. The agency denied the company’s request to remove a currently required warning stating that the products can cause gum disease and tooth loss. With respect to the company’s other requests to remove or revise two additional currently required warnings, the agency deferred final action and issued a response that offers the company an option to amend its applications.
Read more: FDA takes action on applications seeking to market modified risk tobacco products

Pharma Reviews: 68th Indian Pharmaceutical Congress to be held in Visakhapatnam in Dec

The three-day Indian Pharmaceutical Congress (IPC) will be held here at the Andhra University from December 16 to 18. Addressing a media ...
Read more: 68th Indian Pharmaceutical Congress to be held in Visakhapatnam in Dec

Pharma Reviews: 68th Indian Pharmaceutical Congress in Vizag from Dec 16

The 68th Indian Pharmaceutical Congress (IPC) will be held at the Andhra ... which is organised by the Indian Pharmaceutical Congress Association ...
Read more: 68th Indian Pharmaceutical Congress in Vizag from Dec 16

Pharma Reviews: The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun Pharma

See I continue to pick Lupin, best manufacturing practices, best ANDA pipeline and one of the best managements you can see in the pharma industry.
Read more: The jewel of the Indian pharma crown has lost its shine: Amit Ranjan on Sun Pharma

US FDA News: FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee

The U.S. Food and Drug Administration today approved Maci (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Maci is the first FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee.
Read more: FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee

Pharma Reviews: Compass: Three companies that stand out in the Pharma space

At a time when the street is busy gauging the impact on India Inc's performance due to demonetisation, the rebound in the Indian pharma market (IPM) ...
Read more: Compass: Three companies that stand out in the Pharma space

Pharma Reviews: Pharma cos to drive growth, diversify products via M&As: Moody's

Global revenue growth for Indian pharma companies has dropped by around 10% in the last five years — their global sales growth slowed to a ...
Read more: Pharma cos to drive growth, diversify products via M&As: Moody's

Pharma Reviews: Pharm.D Graduation Day Ceremony - 2016 of JKKNattraja College of Pharmacy & Research

D Graduation Day Ceremony - 2016 of J.K.K.Nattraja College of Pharmacy & ... should involve in the development of Indian Pharmaceutical industry.
Read more: Pharm.D Graduation Day Ceremony - 2016 of JKKNattraja College of Pharmacy & Research

Pharma Reviews: What is the way forward for Indian vaccine industry?

The success of the Indian vaccine industry is undoubtedly another jewel in India's crown as the 'Pharmacy of the world'. As the industry stands ...
Read more: What is the way forward for Indian vaccine industry?

Pharma Reviews: Indian drug cos bet on global M&As in growth pursuit: Moody's

New Delhi, Dec 12: Indian drug companies will continue scouting for acquiring overseas assets over the next two years to enhance their presence in ...
Read more: Indian drug cos bet on global M&As in growth pursuit: Moody's

Pharma Reviews: Indian drug makers to focus on inorganic growth, US remains key market: Moody's

In the next 18-24 months, the US generic drugs market may grow around 10%, supported by $20-25 billion worth of branded drugs going off patent ...
Read more: Indian drug makers to focus on inorganic growth, US remains key market: Moody's

Pharma Reviews: Pharma market grew 15% in November on higher sales of drugs for chronic ailments

Anti-diabetic market grew at 32.6% and cardiac market grew at 20.88%,” AIOCD-AWACS said in its monthly report on Indian pharma market, adding ...
Read more: Pharma market grew 15% in November on higher sales of drugs for chronic ailments

US FDA News: Pioglitazone-containing Medicines: Drug Safety Communication - Updated FDA Review, Increased Risk of Bladder Cancer

FDA approved label updates to describe additional studies reviewed.
Read more: Pioglitazone-containing Medicines: Drug Safety Communication - Updated FDA Review, Increased Risk of Bladder Cancer

Pharma Reviews: Pharma cos to drive growth, diversify products via M&As: Moody's

Indian generic pharma majors are expected to explore these M&As amid slowing growth in their global revenue, according to the firm's latest report on ...
Read more: Pharma cos to drive growth, diversify products via M&As: Moody's

Pharma Reviews: Acquisitions To Drive Indian Drug Firms' Near-Term Growth: Moody's And ICRA

Indian pharmaceutical companies will seek growth through acquisitions in the next 18-24 months, according to Moody's Investors Service and its ...
Read more: Acquisitions To Drive Indian Drug Firms' Near-Term Growth: Moody's And ICRA

Pharma Reviews: Indian drug companies bet on global M&As in growth pursuit: Moody's

NEW DELHI: Indian drug companies will continue scouting for acquiring overseas assets over the next two years to enhance their presence in ...
Read more: Indian drug companies bet on global M&As in growth pursuit: Moody's

Pharma Reviews: Nifty ends below 8200, Sensex tanks 232 pts; auto, bank slide

2:41 pm Moody's on pharma: Indian drug companies will continue scouting for acquiring overseas assets over the next two years to enhance their ...
Read more: Nifty ends below 8200, Sensex tanks 232 pts; auto, bank slide

Pharma Reviews: Indian pharma market grew by 15.3% to

The Indian Pharmaceutical Market (IPM) achieved growth of 15.3 per cent to Rs.9,388 crore during November 2016 as against 9.8 per cent in ...
Read more: Indian pharma market grew by 15.3% to

Pharma Reviews: See Indian drug cos growing inorganically in 18-24 mnths:Moody's

The Indian pharma companies will look at the US, Russia for inorganic growth ... The total market of Indian pharma sector is pegged at USD 14 billion, ...
Read more: See Indian drug cos growing inorganically in 18-24 mnths:Moody's

Pharma Reviews: Selling pressure continues on D-St; Asain Paints, Axis Bank fall

ONGC, NTPC, Reliance, Sun Pharma and Coal India are top gainers while ... The Indian pharma companies will look at the US, Russia for inorganic ...
Read more: Selling pressure continues on D-St; Asain Paints, Axis Bank fall

Pharma Reviews: Creation of Indian Drug Service mooted on par with other civil services

A proposal to create Indian Drug Service (IDS) on the lines of Indian ... Indian Pharmaceutical Association (IPA), Indian Pharmacists Graduate ...
Read more: Creation of Indian Drug Service mooted on par with other civil services

Pharma Reviews: M&A activity to fuel growth for India's pharma sector

Strong financial portfolios of the Indian pharma companies are well capable of large acquisitions, which will in turn tap its growth further.
Read more: M&A activity to fuel growth for India's pharma sector

Pharma Reviews: Time to review pharma companies' disclosures?

ET Intelligence Group: Disclosure to stock exchanges by listed Indian pharma companies is becoming a tricky affair as companies adopt a ...
Read more: Time to review pharma companies' disclosures?

Pharma Reviews: Mozambique raises quality concerns on Indian drug exports

This communication from Mozambique has come to light after the drug regulator of Vietnam took a major step of blacklisting 39 Indian pharmaceutical ...
Read more: Mozambique raises quality concerns on Indian drug exports

Pharma Reviews: India's therapeutic jungle

At the same time, the Indian pharmaceutical industry carries a dubious distinction of producing and supplying the maximum number of irrational and ...
Read more: India's therapeutic jungle

Pharma Reviews: It's wait and watch for pharma industry

The pharmaceutical firms – small, medium and big – were looking at the high court to stop the government and the Drugs Controller General of India ...
Read more: It's wait and watch for pharma industry

Pharma Reviews: Minebea Intec invests Euro 1 mn, to tap pharma industry with high-precision weighing ...

Minebea in India, the erstwhile Sartorius Intec which slated a Euro 1 million investment is now gearing up to increase its footprint in India to maximize ...
Read more: Minebea Intec invests Euro 1 mn, to tap pharma industry with high-precision weighing ...

US FDA News: Convenience Kits containing Multi-Med Single Lumen Catheters by Centurion: Class I Recall - Excess Material May Split or Separate

Excess material may separate from catheter during use and enter patient’s bloodstream, resulting in serious adverse health consequences such as blood clots, embolism of the excess material to vital organs, or death.
Read more: Convenience Kits containing Multi-Med Single Lumen Catheters by Centurion: Class I Recall - Excess Material May Split or Separate

US FDA News: FDA takes action against four tobacco manufacturers for illegal sales of flavored cigarettes labeled as little cigars or cigars

The U.S. Food and Drug Administration today issued warning letters to four tobacco manufacturers — Swisher International Inc., Cheyenne International LLC, Prime Time International Co. and Southern Cross Tobacco Company Inc. — for selling flavored cigarettes that are labeled as little cigars or cigars, which is a violation of the Family Smoking Prevention and Tobacco Control Act. The companies received warning letters for products under the “Swisher Sweets,” Cheyenne,” “Prime Time” and “Criss-Cross” brands in a variety of youth-appealing flavors, including grape, cherry, wild cherry and strawberry.
Read more: FDA takes action against four tobacco manufacturers for illegal sales of flavored cigarettes labeled as little cigars or cigars

Pharma Reviews: Indian Pharma industry to hire...

Singapore: In order to bring the Indian Pharmaceutical industry at par with international standards, the Ministry of Health and Family Welfare will now ...
Read more: Indian Pharma industry to hire...

Pharma Reviews: Bombay HC Rejects Taj Pharma Directors' Anticipatory Bail Plea

It was also claimed that Taj is an established company in the Indian market of manufacturing of pharmaceutical products and as such their ...
Read more: Bombay HC Rejects Taj Pharma Directors' Anticipatory Bail Plea

Pharma Reviews: Indian pharma faces challenging times, revenue growth only 9.4% in Q2: ICRA

ICRA expects growth trajectory for Indian pharmaceutical industry to moderate on back of slowing growth from US given the relatively moderate ...
Read more: Indian pharma faces challenging times, revenue growth only 9.4% in Q2: ICRA

Pharma Reviews: Indian pharma industry facing growth headwinds: ICRA

Indian pharmaceutical industry will grow at a slower pace due to sluggish growth in the US market, increased competition leading to price erosion in ...
Read more: Indian pharma industry facing growth headwinds: ICRA

Pharma Reviews: Indian pharma industry facing growth headwinds: ICRA

NEW DELHI: Indian pharmaceutical industry will grow at a slower pace due to sluggish growth in the US market, increased competition leading to ...
Read more: Indian pharma industry facing growth headwinds: ICRA

Pharma Reviews: India committed to adopt advanced technology to drive supply chain integrity of medicines: SM ...

There has been a paradigm shift in the industry's approach for determination of quality and safety of drug products going beyond the end product ...
Read more: India committed to adopt advanced technology to drive supply chain integrity of medicines: SM ...

Pharma Reviews: Sun Pharma says US finds more concerns at Halol plant

Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Wednesday the U.S. health regulator has informed the company of more ...
Read more: Sun Pharma says US finds more concerns at Halol plant

US FDA News: FDA takes steps to improve hearing aid accessibility

The U.S. Food and Drug Administration today announced important steps to better support consumer access to hearing aids. The agency issued a guidance document explaining that it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver prior to purchasing most hearing aids. This guidance is effective immediately. Today, the FDA is also announcing its commitment to consider creating a category of over-the-counter (OTC) hearing aids that could deliver new, innovative and lower-cost products to millions of consumers.
Read more: FDA takes steps to improve hearing aid accessibility

Pharma Reviews: Pharma industry gets ultimatum to employee qualified personnel

To bring the Indian pharmaceutical and biotechnology industry at par with international standards, the Ministry of Health and Family Welfare will seek ...
Read more: Pharma industry gets ultimatum to employee qualified personnel

Pharma Reviews: Dealtalk: Trump's corporate tax holiday could spur pharma M&A

U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of ...
Read more: Dealtalk: Trump's corporate tax holiday could spur pharma M&A

Pharma Reviews: Laurus Labs coming with an IPO to raise Rs 1331.80 crore

The company is a leading research and development (R&D) driven pharmaceutical company in India, with a leadership position in generic active ...
Read more: Laurus Labs coming with an IPO to raise Rs 1331.80 crore

Pharma Reviews: Clariant to tap Indian pharma sector with packaging and anti-counterfeit solutions

The company caters to Indian pharmaceutical and healthcare sector through its two business lines - healthcare packaging and healthcare polymer ...
Read more: Clariant to tap Indian pharma sector with packaging and anti-counterfeit solutions

Pharma Reviews: EMA, US FDA to sign pact for joint inspection of plants in January 2017, may be extended to Asia

In the wake of this landmark development which would transform the speed of global audits, Indian pharma industry is hoping that this pact would be ...
Read more: EMA, US FDA to sign pact for joint inspection of plants in January 2017, may be extended to Asia

Pharma Reviews: 100 pharma cos join hands with CDSCO, PvPI to frame guidelines for good PvP practices

Pharmaco-vigilance programme of India (PvPI) had mandated pharmaceutical companies to submit their ADR reports in XML -E2B towards building ...
Read more: 100 pharma cos join hands with CDSCO, PvPI to frame guidelines for good PvP practices

Pharma Reviews: Bomaby High Court denies promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory ...

"Justice Nitin Sambre rejected the anticipatory bail petition on the grounds of bringing disrepute to Indian pharma industry," said Hitesh Jain of law firm ...
Read more: Bomaby High Court denies promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory ...

Pharma Reviews: Delhi High Court Strikes Down Ban on 344 Fixed Dose Combination Drugs

ELP also filed over 25 separate writ petitions for individual Indian Pharma companies including Biocon Limited. Other Pharma Companies also ...
Read more: Delhi High Court Strikes Down Ban on 344 Fixed Dose Combination Drugs

Pharma Reviews: India: Delhi High Court Strikes Down Notification Dated 10 March 2016 Issued By The Government ...

Needless to say, the Notification adversely affected almost the entire Indian pharmaceutical industry; and had the Notification gone unchallenged – the ...
Read more: India: Delhi High Court Strikes Down Notification Dated 10 March 2016 Issued By The Government ...

US FDA News: FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
Read more: FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

Pharma Reviews: Lupin Partners Eli Lilly To Market Diabetes Drug 'Eglucent'

New Delhi: Pharma major Lupin on Thursday announced a new partnership with Eli Lilly India to market and sell the latter's diabetes treatment drug ...
Read more: Lupin Partners Eli Lilly To Market Diabetes Drug 'Eglucent'

Pharma Reviews: Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally

But, the rest of India's pharmaceutical industry remains sceptical. While the country's mastery over low-cost copies of simple chemical medicines has ...
Read more: Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally

Pharma Reviews: GST implementation to see dip in job creation from the current 14% to 13%

With the implementation of GST (goods and services tax), the Indian pharma industry is expected to see a one per cent dip in job creation from the ...
Read more: GST implementation to see dip in job creation from the current 14% to 13%

Pharma Reviews: China looking to buy Indian pharma

BEIJING: Chinese investors are looking at opportunities to acquire pharmaceutical companies in India, an expert with a government-backed think tank ...
Read more: China looking to buy Indian pharma

Pharma Reviews: Delhi HC quashes ban on 344 fixed dose combination drugs, says govt did it in 'haphazard manner'

In a boost to the pharmaceutical industry, the Delhi High Court on Thursday ... The drug regulatory mechanism in India needs to be more stable, ...
Read more: Delhi HC quashes ban on 344 fixed dose combination drugs, says govt did it in 'haphazard manner'

Pharma Reviews: Lupin in diabetes drug pact

1: Pharma majors Lupin and Eli Lilly and Company (India) Pvt Ltd today expanded their partnership to Lilly's diabetes fighter Eglucent for the Indian ...
Read more: Lupin in diabetes drug pact

Pharma Reviews: Sun Pharma in race for UK buyout in hospital-initiated & emergency care segment

... equity players and a few Indian suitors may be interested as well," said one of ... Bolt Equity Limited trades as Martindale Pharma and is an established ... "Sun Pharma does not have a substantial presence in the UK market which ...
Read more: Sun Pharma in race for UK buyout in hospital-initiated & emergency care segment

Pharma Reviews: 'China may open its Pharma industry to India for mutual gain'

"China and India are the world's two largest manufacturers of bulk drugs, a key raw material for producing pharmaceutical drugs," an article in the ...
Read more: 'China may open its Pharma industry to India for mutual gain'

Pharma Reviews: FDC ban controversy: Appeals expected, as pharma industry gets a breather

Data from the AIOCD (All India Organisation of Chemists and Druggists) pegged the FDC ban impact at about 3 percent of the Indian pharmaceutical ...
Read more: FDC ban controversy: Appeals expected, as pharma industry gets a breather

Pharma Reviews: Lupin partners Eli Lilly to market diabetes drug 'Eglucent'

NEW DELHI: Pharma major Lupin today announced a new partnership with Eli Lilly India to market and sell the latter's diabetes treatment drug ...
Read more: Lupin partners Eli Lilly to market diabetes drug 'Eglucent'

Pharma Reviews: How Kiran Shaw Shut Up Her Twitter Trolls With Pharma Stock Rally

But the rest of India's pharmaceutical industry remains skeptical. While the country's mastery over low-cost copies of simple chemical medicines has ...
Read more: How Kiran Shaw Shut Up Her Twitter Trolls With Pharma Stock Rally

Pharma Reviews: Surprise, surprise! Pharma stocks beat peers and here's how

As per the brokerage firm, most Indian generic firms have already increased expectation of price erosion from mid-single digit to high single digit post ...
Read more: Surprise, surprise! Pharma stocks beat peers and here's how

Pharma Reviews: China eyeing India's pharma industry in bid to go global

China, for its part, is lagging behind when it comes to manufacturing generic drugs, and its firms are struggling to compete with Western ones both at ...
Read more: China eyeing India's pharma industry in bid to go global

Pharma Reviews: Experts welcome India's denial of patent to prostrate cancer drug, Xtandi

Experts welcome India's denial of patent to prostrate cancer drug, Xtandi ... Indian Pharmaceutical Alliance, an organisation of 20 research based ...
Read more: Experts welcome India's denial of patent to prostrate cancer drug, Xtandi

US FDA News: Megajex Natural Male Sex Enhancer by MS Bionic: Recall - Undeclared Drug Ingredients

Undeclared tadalafil and sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
Read more: Megajex Natural Male Sex Enhancer by MS Bionic: Recall - Undeclared Drug Ingredients

US FDA News: Ultimate Body Tox PRO: Recall - Undeclared Drug Ingredient

Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Read more: Ultimate Body Tox PRO: Recall - Undeclared Drug Ingredient